Genprex, Inc. Files 8-K Report
Ticker: GNPX · Form: 8-K · Filed: May 6, 2025 · CIK: 1595248
| Field | Detail |
|---|---|
| Company | Genprex, Inc. (GNPX) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, regulatory-filing
Related Tickers: GNPX
TL;DR
Genprex filed an 8-K. Mostly routine financial stuff, no major news.
AI Summary
On May 6, 2025, Genprex, Inc. filed an 8-K report. The filing primarily concerns the company's financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The report confirms Genprex, Inc.'s incorporation in Delaware and provides its principal executive office address in Austin, Texas.
Why It Matters
This filing serves as a routine update for investors and regulatory bodies, confirming the company's operational status and providing access to its financial disclosures.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not disclose any new material risks or significant negative events.
Key Numbers
- 001-38244 — SEC File Number (Identifies the company's filing with the SEC.)
- 90-0772347 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- Genprex, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Austin, TX (location) — Principal executive offices
- May 6, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing by Genprex, Inc.?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits', indicating it's a routine update and disclosure of financial information.
When was this 8-K report filed with the SEC?
This 8-K report was filed on May 6, 2025.
In which state is Genprex, Inc. incorporated?
Genprex, Inc. is incorporated in Delaware.
What is the principal executive office address for Genprex, Inc.?
The principal executive office address for Genprex, Inc. is 3300 Bee Cave Road, #650-227, Austin, TX 78746.
Does this filing indicate any specific new business developments or material events for Genprex, Inc.?
Based on the provided text, this filing primarily concerns routine reporting of financial statements and exhibits, and does not explicitly detail any specific new business developments or material events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Genprex, Inc. (GNPX).